Evaluating Safety ,Tolerability, Pharmacokinetic,Efficacy of WJ01024 or WJ01024 Combined With Ruxolitinib in Patients With Myelofibrosis (clinicaltrials.gov) - Sep 4, 2026 - P1 | N=20 | Recruiting | Sponsor: Henan Cancer Hospital
Monotherapy • New P1 trial • Myelofibrosis
|